The forecast for the share of the US's scientific publications in Biochemistry, Genetics, and Molecular Biology that fall within the world's 10% top-cited category is projected to remain stable from 2024 through 2027 at 14.34%, with a slight decline to 14.33% in 2028. This reflects a stagnation in growth compared to 2023's actual performance within this metric, suggesting no significant year-on-year changes and indicating a flat Compound Annual Growth Rate (CAGR) over the forecast period.
Future trends to watch include potential shifts in global research dynamics, technological advancements in the field, and policy changes that may impact funding and publication practices. Keeping an eye on these factors could provide insights into future performance and direction in this research area.
